Ronald L. Dalman MD

Clinical Focus

• Vascular Surgery
• Aortic Aneurysm
• Limb Salvage
• Aortic Diseases
• Aorta, Abdominal
• Aortic Aneurysm, Thoracic
• Aortitis
• Intermittent Claudication
• Diabetic Foot
• Cerebrovascular Disorders
• Transient Ischemic Attack, Carotid Circulation
• Carotid Artery Diseases
• Carotid Stenosis
• Stroke
• Venous Insufficiency
• Mesenteric Vascular Occlusion
• Hypertension, Renovascular
• Iliac Aneurysm
• Deep Vein Thrombosis
• Subclavian Vein
• Subclavian Steal Syndrome

Administrative Appointments

• Program Director, Vascular Surgery Residency Program, Stanford University School of Medicien , (2005– present )
• Director, Vascular Center, Stanford Hospital and Clinics , (2005– present )
• Professor and Chief, Division of Vascular Surgery, Stanford University School of Medicine , (2005– present )

Honors and Awards

• Chair, Research Council, Society for Vascular Surgery (2008-2010)
• Ad hoc member, Biotechnology and Surgical Sciences Study Section, Center for Scientific Review, NIH (2003-2005)
• President, Silicon Valley Affiliate, American Heart Association (1999-2000)
• Chairman, Membership Committee, Society for Vascular Surgery (2001)
• E. J. Wylie Travelling Fellowship in Vascular Surgery, Lifeline Foundation (2000 -2001)

Professional Education

• Board Certification: Vascular Surgery, American Board of Surgery (1992)
• Oregon Health Sciences Univ Hospital (1991) OR
• Board Certification: General Surgery, American Board of Surgery (1990)
• University of Washington Medical Center (1989) WA USA
• U. Washington (1985)
• University of Michigan School of Medicine (1984) MI
• Fellowship, Texas Tech University Endovascular Surgery (2003)
• Fellowship, Oregon Health Sciences Univ. Vascular Surgery (1991)
• Surgical Residency, Univ. of Washington, Seattle Surgery (1989)
• MD, .University of Michigan - Ann Arbor .Medicine (1984)

Postdoctoral Advisees

• Monica Dua, Noriyuki Miyama

Graduate & Fellowship Program Affiliations

• Biomechanical Engineering
• Medicine
• Surgery
• Bioengineering

Community & International Work

• See Biosketch, . More »

Web Site Links

• Vascular Division Webpage

Research Interests

We are investigating the biologic and mechanical basis of aneurysmal degeneration of the aorta. We use molecular, imaging and computer modeling modalities to identify novel treatment strategies for small AAAs and hybrid drug/device surgical solutions for larger AAAs.

By extension we are keenly interested in new surgical technology and its application to aneurysmal and
occlusive arterial and venous diseases. To this end we have completed over 50 drug and device clinical trials from dozens of governmental and commercial sponsors in our SUMC and VA clinical practices. We are currently enrolling patients in over a dozen clinical trials at both sites. Please review our website (vascular.stanford.edu) for updates regarding clinical trials and eligibility criteria.

Clinical Trials

• Abdominal Aortic Aneurysms: Simple Treatment or Prevention (AAA: STOP) Recruiting
• Abbott Vascular Carotid Stent Systems and Embolic Protection Systems to treat Carotid Artery Stenosis in High Surgical-Risk Patients Recruiting
• Endovascular repair of abdominal aortic aneurysm with angled aorta, angled aneurysmal body or both. Recruiting
• Safety and effectiveness study of Endurant Stent Graft System as endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms. Recruiting
• Stenting procedure with distal protection in the treatment of obstructive carotid artery disease in high-surgical risk patients with atherosclerotic disease of the carotid artery(ies) Recruiting
• Study of Zenith® Low Profile AAA Endovascular Graft to treat abdominla aortic aneurysm Recruiting
• Treatment of atherosclerotic carotid artery disease in high-surgical risk subjects with carotid stent used in conjunction with the new generation of filter protection system. No longer recruiting
• Compare endovascular repair versus surveillance on patient with small abdominal aortic aneurysm (4-5 cm) No longer recruiting
• Compare the outcome of bypass surgery and plaque excision for treatment of critical limb ischemia in the lower limbs Completed
• Safety and efficacy study of a 31mm bifurcated endoprosthesis system in the treatment of infrarenal abdominal aortic aneurysms No longer recruiting

Publications

• Identifying abdominal aortic aneurysm risk factors in postmenopausal women. Dua MM,  Dalman RL.  Womens Health (Lond Engl).  2009; 5 (1): 33-7
• Reduction of postprocedure microemboli following retrospective quality assessment and practice improvement measures for carotid angioplasty and stenting. Tedesco MM,  Dalman RL, Zhou W, Coogan SM, Lane B, Lee JT.  J Vasc Surg.  2009; 49 (3): 607-12; discussion 612-3
• Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Leeper NJ,  Tedesco MM, Kojima Y, Schultz GM, Kundu RK, Ashley EA, Tsao PS, Dalman RL, Quertermous T.  Am J Physiol Heart Circ Physiol.  2009; 296 (5): H1329-35
• Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression. Tedesco MM,  Terashima M, Blankenberg FG, Levashova Z, Spin JM, Backer MV, Backer JM, Sho M, Sho E, McConnell MV, Dalman RL.  Arterioscler Thromb Vasc Biol.  2009; 29 (10): 1452-7
• Preoperative thrombus volume predicts sac regression after endovascular aneurysm repair. Yeung JJ,  Hernandez-Boussard TM, Song TK, Dalman RL, Lee JT.  J Endovasc Ther.  2009; 16 (3): 380-8
• The three-dimensional micro- and nanostructure of the aortic medial lamellar unit measured using 3D confocal and electron microscopy imaging. O'Connell MK,  Murthy S, Phan S, Xu C, Buchanan J, Spilker R, Dalman RL, Zarins CK, Denk W, Taylor CA.  Matrix Biol.  2008; 27 (3): 171-81
• Simulation-based endovascular skills assessment: the future of credentialing? Tedesco MM,  Pak JJ, Harris EJ, Krummel TM, Dalman RL, Lee JT.  J Vasc Surg.  2008; 47 (5): 1008-1; discussion 1014
• Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. Zacharski LR,  Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.  J Natl Cancer Inst.  2008; 100 (14): 996-1002
• Risk factors for developing postprocedural microemboli following carotid interventions. Tedesco MM,  Coogan SM, Dalman RL, Haukoos JS, Lane B, Loh C, Penkar TS, Lee JT.  J Endovasc Ther.  2007; 14 (4): 561-7
• Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. Zacharski LR,  Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW.  JAMA.  2007; 297 (6): 603-10
• Postprocedural microembolic events following carotid surgery and carotid angioplasty and stenting. Tedesco MM,  Lee JT, Dalman RL, Lane B, Loh C, Haukoos JS, Rapp JH, Coogan SM.  J Vasc Surg.  2007; 46 (2): 244-50
• AAA disease: mechanism, stratification, and treatment. Dalman RL,  Tedesco MM, Myers J, Taylor CA.  Ann N Y Acad Sci.  2006; 1085 92-109
• Allometric scaling of wall shear stress from mice to humans: quantification using cine phase-contrast MRI and computational fluid dynamics. Greve JM,  Les AS, Tang BT, Draney Blomme MT, Wilson NM, Dalman RL, Pelc NJ, Taylor CA.  Am J Physiol Heart Circ Physiol.  2006; 291 (4): H1700-8
• Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms. Sho E,  Sho M, Nanjo H, Kawamura K, Masuda H, Dalman RL.  J Vasc Surg.  2005; 41 (5): 844-52
• Hemodynamic forces regulate mural macrophage infiltration in experimental aortic aneurysms. Sho E,  Sho M, Hoshina K, Kimura H, Nakahashi TK, Dalman RL.  Exp Mol Pathol.  2004; 76 (2): 108-16
• Hemodynamic regulation of CD34+ cell localization and differentiation in experimental aneurysms. Sho E,  Sho M, Nanjo H, Kawamura K, Masuda H, Dalman RL.  Arterioscler Thromb Vasc Biol.  2004; 24 (10): 1916-21
• Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms. Sho E,  Chu J, Sho M, Fernandes B, Judd D, Ganesan P, Kimura H, Dalman RL.  J Vasc Surg.  2004; 39 (6): 1312-21
• Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm. Hoshina K,  Koyama H, Miyata T, Shigematsu H, Takato T, Dalman RL, Nagawa H.  J Vasc Surg.  2004; 40 (3): 512-8
• Wall shear stress and strain modulate experimental aneurysm cellularity. Hoshina K,  Sho E, Sho M, Nakahashi TK, Dalman RL.  J Vasc Surg.  2003; 37 (5): 1067-74
• Oxidative stress and abdominal aneurysms: how aortic hemodynamic conditions may influence AAA disease. Dalman RL,  Cardiovasc Surg.  2003; 11 (5): 417-9
• Transition to all-autogenous hemodialysis access: the role of preoperative vein mapping. Dalman RL,  Harris EJ, Victor BJ, Coogan SM.  Ann Vasc Surg.  2002; 16 (5): 624-30
• Treatment of abdominal aortic anastomotic pseudoaneurysm with percutaneous coil embolization. Fann JI,  Samuels S, Slonim S, Burdon TA, Dalman RL.  J Vasc Surg.  2002; 35 (4): 811-4
• Open versus endovascular AAA repair in patients who are morphological candidates for endovascular treatment. Hill BB,  Wolf YG, Lee WA, Arko FR, Olcott C, Schubart PJ, Dalman RL, Harris EJ, Fogarty TJ, Zarins CK.  J Endovasc Ther.  2002; 9 (3): 255-61
• Aneurysm-related death: primary endpoint analysis for comparison of open and endovascular repair. Arko FR,  Lee WA, Hill BB, Olcott C, Dalman RL, Harris EJ, Cipriano P, Fogarty TJ, Zarins CK.  J Vasc Surg.  2002; 36 (2): 297-304
• Spontaneous late carotid-cutaneous fistula following radical neck dissection: a case report. Rodriguez F,  Carmeci C, Dalman RL, Lee WA.  Vasc Surg.  2001 Sep-Oct; 35 (5): 409-13
• Impact of endovascular repair on open aortic aneurysm surgical training. Arko FR,  Lee WA, Hill BB, Olcott C, Harris EJ, Dalman RL, Fogarty TJ, Zarins CK.  J Vasc Surg.  2001; 34 (5): 885-91
• Duplex surveillance of abdominal aortic stent grafts. Johnson BL,  Dalman RL.  Semin Vasc Surg.  2001; 14 (3): 227-32
• Endovascular repair of abdominal aortic aneurysms: eligibility rate and impact on the rate of open repair. Wolf YG,  Fogarty TJ, Olcott C IV, Hill BB, Harris EJ, Mitchell RS, Miller DC, Dalman RL, Zarins CK.  J Vasc Surg.  2000; 32 (3): 519-23
• Will endovascular repair replace open surgery for abdominal aortic aneurysm repair? Zarins CK,  Wolf YG, Lee WA, Hill BB, Olcott C IV, Harris EJ, Dalman RL, Fogarty TJ.  Ann Surg.  2000; 232 (4): 501-7
• Modular systems in the treatment of abdominal aortic aneurysms: lessons learned in the development of designer endografts. Harris EJ,  Semin Vasc Surg.  1999; 12 (3): 170-5
• In vivo flow-independent T2 measurements of superior mesenteric vein blood in diagnosis of chronic mesenteric ischemia: a preliminary evaluation. Li KC,  Dalman RL, Wright GA.  Acad Radiol.  1999; 6 (9): 530-4
• Reoperation for carotid stenosis is as safe as primary carotid endarterectomy. Hill BB,  Olcott C, Dalman RL, Harris EJ, Zarins CK.  J Vasc Surg.  1999; 30 (1): 26-35
• Limb salvage surgery in spinal cord injury patients. Dalman RL,  Harris EJ, Walker MT, Perkash I.  Ann Vasc Surg.  1998; 12 (1): 60-4
• Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model. Abbruzzese TA,  Guzman RJ, Martin RL, Yee C, Zarins CK, Dalman RL.  Surgery.  1998; 124 (2): 328-34; discussion 334-5
• Matrix metalloproteinase inhibition decreases flow mediated arterial enlargement Abbruzzese TA,  Guzman RL, Martin RL, Zarins CK, Dalman RL.  Circulation (suppl).  1997; 96 I-172
• In vivo magnetic resonance evaluation of blood oxygen saturation in the superior mesenteric vein as a measure of the degree of acute flow reduction in the superior mesenteric artery: findings in a canine model. Li KC,  Pelc LR, Dalman RL, Wright GA, Hollett MD, Ch'en I, Song CK, Porath TS.  Acad Radiol.  1997; 4 (1): 21-5
• Chronic mesenteric ischemia: use of in vivo MR imaging measurements of blood oxygen saturation in the superior mesenteric vein for diagnosis. Li KC,  Dalman RL, Ch'en IY, Pelc LR, Song CK, Moon WK, Kang MI, Wright GA.  Radiology.  1997; 204 (1): 71-7
• Subclavian vein thrombosis: outcome analysis based on etiology and modality of treatment. Beygui RE,  Olcott C, Dalman RL.  Ann Vasc Surg.  1997; 11 (3): 247-55
• Upper extremity revascularization proximal to the wrist. Dalman RL,  Olcott C.  Ann Vasc Surg.  1997; 11 (6): 643-50
• Diminished postprandial hyperemia in patients with aortic and mesenteric arterial occlusive disease. Quantification by magnetic resonance flow imaging. Dalman RL,  Li KC, Moon WK, Chen I, Zarins CK.  Circulation.  1996; 94 (9 Suppl): II206-10
• Is completion arteriography mandatory after reversed-vein bypass grafting? Dalman RL,  Harris EJ, Zarins CK.  J Vasc Surg.  1996; 23 (4): 637-44
• Oxygen saturation of blood in the superior mesenteric vein: in vivo verification of MR imaging measurements in a canine model. Work in progress. Li KC,  Wright GA, Pelc LR, Dalman RL, Brittain JH, Wegmueller H, Lin DT, Song CK.  Radiology.  1995; 194 (2): 321-5
• Simultaneous measurement of flow in the superior mesenteric vein and artery with cine phase-contrast MR imaging: value in diagnosis of chronic mesenteric ischemia. Work in progress. Li KC,  Hopkins KL, Dalman RL, Song CK.  Radiology.  1995; 194 (2): 327-30
• Extra-anatomic bypass. Fann JI,  Harris EJ, Dalman RL.  Ann Vasc Surg.  1993; 7 (4): 378-83
• Genetic and metabolic causes of arterial disease. Fann JI,  Dalman RL, Harris EJ.  Ann Vasc Surg.  1993; 7 (6): 594-604
• Heritable arteriopathy. Fann JI,  Dalman RL.  Semin Vasc Surg.  1993; 6 (1): 46-55